These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30184310)

  • 1. Impact of antiretroviral regimen on renal transplant outcomes in HIV-infected recipients.
    Sparkes T; Manitpisitkul W; Masters B; Bartlett ST; Davis C; Husson J; Amoroso A; Haririan A
    Transpl Infect Dis; 2018 Dec; 20(6):e12992. PubMed ID: 30184310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher rates of rejection in HIV-infected kidney transplant recipients on ritonavir-boosted protease inhibitors: 3-year follow-up study.
    Rollins B; Farouk S; DeBoccardo G; Lerner S; Rana M; Huprikar S; Miko L; Delaney V; Florman S; Shapiro R
    Clin Transplant; 2019 Jun; 33(6):e13534. PubMed ID: 30864166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Protease Inhibitor-Based Antiretroviral Therapy on Tacrolimus Intrapatient Variability in HIV-Positive Kidney Transplant Recipients.
    Cooper M; Dunne I; Kuten S; Curtis A; Graviss EA; Nguyen DT; Hobeika M; Gaber AO
    Transplant Proc; 2021 Apr; 53(3):984-988. PubMed ID: 33246588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.
    Sayin B; Canver B; Gurlek Demirci B; Colak T; Ozdemir BH; Haberal M
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):32-36. PubMed ID: 28260428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-Specific Anti-Human Leukocyte Antigens Antibodies, Acute Rejection, Renal Function, and Histology in Kidney Transplant Recipients Receiving Tacrolimus and Everolimus.
    Ferreira A; Felipe C; Cristelli M; Viana L; Basso G; Stopa S; Mansur J; Ivani M; Bessa A; Ruppel P; Aguiar W; Campos E; Gerbase-DeLima M; Proença H; Tedesco-Silva H; Medina-Pestana J
    Am J Nephrol; 2017; 45(6):497-508. PubMed ID: 28511172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal transplantation in human immunodeficiency virus-infected recipients: a case-control study from the Brazilian experience.
    Vicari AR; Spuldaro F; Sandes-Freitas TV; Cristelli MP; Requião-Moura LR; Reusing JO; Pierrotti LC; Oliveira ML; Girão CM; Gadonski G; Kroth LV; Deboni LM; Ferreira GF; Tedesco-Silva H; Esmeraldo R; David-Neto E; Saitovitch D; Keitel E; Garcia VD; Pacheco-Silva A; Medina-Pestana JO; Manfro RC
    Transpl Infect Dis; 2016 Oct; 18(5):730-740. PubMed ID: 27503081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrase strand transferase inhibitors: the preferred antiretroviral regimen in HIV-positive renal transplantation.
    Azar MM; Malinis MF; Moss J; Formica RN; Villanueva MS
    Int J STD AIDS; 2017 Apr; 28(5):447-458. PubMed ID: 27193421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infectious complications in HIV-infected kidney transplant recipients.
    Ailioaie O; Arzouk N; Valantin MA; Tourret J; Calin RO; Turinici M; Mircescu G; Barrou B
    Int J STD AIDS; 2018 Mar; 29(4):341-349. PubMed ID: 28862528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney transplantation in HIV-positive patients treated with a steroid-free immunosuppressive regimen.
    Bossini N; Sandrini S; Casari S; Tardanico R; Maffeis R; Setti G; Valerio F; Forleo MA; Nodari F; Cancarini G
    Transpl Int; 2014 Oct; 27(10):1050-9. PubMed ID: 24964311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients.
    Gathogo E; Harber M; Bhagani S; Levy J; Jones R; Hilton R; Davies G; Post FA;
    Transplantation; 2016 Apr; 100(4):871-8. PubMed ID: 26413990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive regimen and interstitial fibrosis and tubules atrophy at 12 months postrenal transplant.
    Gelens MA; Steegh FM; van Hooff JP; van Suylen RJ; Nieman FH; van Heurn LW; Peutz-Kootstra CJ; Christiaans MH
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):1010-7. PubMed ID: 22490875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppression and Graft Rejection in Living-related HLA-identical Renal Transplantation: The RADOVFULL Study.
    Ossman R; Jamme M; Moulin B; Legendre C; Morelon E; Frimat L; Hourmant M; Durrbach A; Malvezzi P; Rostaing L; Luc Taupin J; Mesnard L; Rondeau E;
    Transplantation; 2020 Jun; 104(6):1256-1262. PubMed ID: 31465001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute rejection features in dual kidney transplant recipients from elderly donors: comparison of calcineurin inhibitor-based and calcineurin inhibitor-free immunosuppressive protocols.
    Aiello FB; Furian L; Marino S; Marchini F; Cardillo M; De Fazio N; Rigotti P; Valente M
    Int J Immunopathol Pharmacol; 2009; 22(4):1001-7. PubMed ID: 20074463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of delayed graft function in HIV-infected kidney transplant recipients.
    Mazuecos A; Fernandez A; Zarraga S; Andres A; Rodriguez-Benot A; Jimenez C; Gomez E; Paul J; Jimeno L; Fernandez C; Burgos D; Sanchez-Fructuoso A; Guirado L
    Transpl Int; 2013 Sep; 26(9):893-902. PubMed ID: 23841527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal transplantation in HIV-infected patients in Spain].
    Mazuecos A; Pascual J; Gómez E; Sola E; Cofán F; López F; Puig-Hooper CE; Baltar JM; González-Molina M; Oppenheimer F; Marcén R; Rivero M
    Nefrologia; 2006; 26(1):113-20. PubMed ID: 16649432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of Serial Protocol Biopsies Performed After 1 Year in Predicting Long-Term Kidney Allograft Function According to Histologic Phenotype.
    Zachariah MS; Dwivedi AK; Yip CS; Chang SS; Gundroo A; Venuto RC; Tomaszewski J; Patel SK; Sharma R
    Exp Clin Transplant; 2018 Aug; 16(4):391-400. PubMed ID: 29206090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Protease Inhibitor-Based Anti-Retroviral Therapy on Outcomes for HIV+ Kidney Transplant Recipients.
    Sawinski D; Shelton BA; Mehta S; Reed RD; MacLennan PA; Gustafson S; Segev DL; Locke JE
    Am J Transplant; 2017 Dec; 17(12):3114-3122. PubMed ID: 28696079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients.
    Locke JE; James NT; Mannon RB; Mehta SG; Pappas PG; Baddley JW; Desai NM; Montgomery RA; Segev DL
    Transplantation; 2014 Feb; 97(4):446-50. PubMed ID: 24162248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.